Understanding how cells die and are cleared from the body

Structural basis of apoptotic scrambling

NIH-funded research Weill Medical Coll of Cornell Univ · NIH-11017015

This study is looking at how certain proteins help dying cells signal the immune system to clear them away, which is important for keeping our bodies healthy, and it aims to find out more about these proteins to help improve treatments for conditions like autoimmune diseases and cancer.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionWeill Medical Coll of Cornell Univ NIH-funded
Lab location1 site (New York, United States)
Project IDNIH-11017015 on NIH RePORTER

What this research studies

This research investigates the process of apoptosis, or programmed cell death, which is crucial for maintaining healthy tissues and recovering from diseases. It focuses on the role of specific proteins, known as phospholipid scramblases, that help externalize certain lipids in dying cells, signaling immune cells to clear them away. By using advanced imaging techniques, the study aims to uncover the molecular structures and functions of these proteins, particularly the XKR family, to better understand their involvement in autoimmune disorders and cancer. Patients may benefit from insights gained into how these processes can be manipulated for therapeutic purposes.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals with autoimmune disorders or those at risk for conditions related to dysfunctional apoptosis.

Not a fit: Patients with conditions unrelated to apoptosis or immune system function may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new treatments for autoimmune diseases and cancer by targeting the mechanisms of cell death and clearance.

How similar studies have performed: Previous research has shown promising results in understanding apoptosis and its implications in various diseases, indicating that this approach has potential for success.

Where this research is happening

New York, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Autoimmune Diseasesautoimmune disorderautoimmunity disease
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.